Upcoming Webinar: Vaccine Efficacy Trials for Crimean Congo Hemorrhagic Fever
Date: Wednesday, July 17, 2024
Time: 12:00 PM EAT
Talk Summary:
Crimean-Congo Haemorrhagic Fever (CCHF) virus (CCHFV) is a zoonotic tick-borne emerging pathogen that can lead to fatal haemorrhagic fever in humans. Despite this, no effective vaccine formulation is currently available, while the epidemiological map of influence for CCHFV keeps expanding. This webinar will explore the feasibility of conducting a phase III vaccine trial for a CCHFV-specific vaccine. Through mathematical models, we will estimate key trial design components such as sample size and time to attain the necessary number of trial endpoints in three different endemic settings: Afghanistan, South Africa, and Turkey.
Speaker Bio:
Dr. Juan Vesga is a Lead Infectious Disease and Vaccine Modeller at the UK Health Security Agency and a visiting researcher at Imperial College London. His work focuses on using mathematical models to understand disease dynamics of preventable diseases and the impact of interventions. His research on CCHF was developed during his time at the London School of Hygiene and Tropical Medicine, where he also developed models for tick-borne diseases like Lyme Disease and Tick-borne Encephalitis.
Register for the Webinar:
Join us for this insightful webinar by registering through the link below: